GTBPVSLQDA• 12 Months (Normalized)
GTBP vs LQDA (GT Biopharma Inc. vs Liquidia Corporation)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+854.62%
GT Biopharma Inc.
Normalized Baseline0.00%
LQDA Performance $28.64
+30.78%
Liquidia Corporation
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+823.84 pts
GTBP outperforming by 823.84 percentage points
GTBPLQDA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP LQDA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | GTBP Price | GTBP Gain (%) | LQDA Price | LQDA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +854.62% | $28.64 | +30.78% | +823.84% |
| Oct 01, 2026 | $- | $27.99 | +27.81% | - | |
| Sep 30, 2026 | $- | $30.26 | +38.17% | - | |
| Sep 29, 2026 | $6.88 | +975.90% | $70.69 | +222.79% | +753.11% |
| Sep 28, 2026 | $6.80 | +964.16% | $73.67 | +236.39% | +727.77% |
| Sep 25, 2026 | $6.89 | +978.25% | $68.43 | +212.47% | +765.78% |
| Sep 24, 2026 | $6.83 | +968.86% | $70.95 | +223.97% | +744.89% |
| Sep 23, 2026 | $7.10 | +1011.11% | $67.49 | +208.17% | +802.94% |
| Sep 22, 2026 | $- | $68.64 | +213.42% | - | |
| Sep 21, 2026 | $7.18 | +1023.63% | $66.43 | +203.33% | +820.30% |
| Sep 18, 2026 | $7.16 | +1020.50% | $66.88 | +205.39% | +815.11% |
| Sep 17, 2026 | $7.49 | +1072.14% | $68.39 | +212.28% | +859.86% |
| Sep 16, 2026 | $7.81 | +1122.22% | $68.45 | +212.56% | +909.66% |
| Sep 15, 2026 | $9.00 | +1308.45% | $65.72 | +200.09% | +1108.36% |
| Sep 14, 2026 | $11.63 | +1720.03% | $65.31 | +198.22% | +1521.81% |
Page 1 of 17